Kymera Therapeutics Announces Pricing of Upsized Public Offering of Common Stock
WATERTOWN, Mass., June 30, 2021 (GLOBE NEWSWIRE) — Kymera Therapeutics, Inc. (NASDAQ: KYMR), a clinical-stage biopharmaceutical company advancing targeted protein…
Pharmaceuticals, Biotechnology and Life Sciences
WATERTOWN, Mass., June 30, 2021 (GLOBE NEWSWIRE) — Kymera Therapeutics, Inc. (NASDAQ: KYMR), a clinical-stage biopharmaceutical company advancing targeted protein…
SAN DIEGO, June 30, 2021 (GLOBE NEWSWIRE) — Ensysce Biosciences, Inc. (“Ensysce” or the “Company”) (OTC: LACQ, LACQW) today announced…
NEW YORK, June 30, 2021 (GLOBE NEWSWIRE) — Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory…
TORONTO, June 30, 2021 (GLOBE NEWSWIRE) — Avicanna Inc. (the “Company” or “Avicanna”) (TSX: AVCN) announced today that the Company’s…
Spero grants Pfizer rights to develop, manufacture, and commercialize SPR206 in ex-U.S. and ex-Asia territories in exchange for potential development…
The Company signed contracts for the manufacturing of registration batches in view of the potential application for Emergency Use Authorization…
PARIS and CAMBRIDGE, Mass., June 30, 2021 (GLOBE NEWSWIRE) — Biophytis SA (Nasdaq CM: BPTS, Euronext Growth Paris: ALBPS), (“Biophytis”…
Ensysce Common Stock to commence trading under ticker symbol “ENSC” on The Nasdaq Capital Market July 1, 2021. Ensysce Warrants…
Collaboration combines Apellis’ expertise in complement, a complex biological system, with Beam’s proprietary base editing platform Companies will collaborate on…
Lille (France); Cambridge (Massachusetts, United States) — June 30, 2021 — GENFIT (Nasdaq and Euronext: GNFT), a late-stage biopharmaceutical company…